leadf
logo-loader
viewDeltex Medical Group plc
(
AIM:DEMG
)

Deltex Medical: Irish and Wippell join board

board_appointment_350_53a00a407f328.jpg

Deltex Medical (LON:DEMG) said Tim Irish and Mark Wippell have now become non- executive directors at the company.

As reported on April 11, the pair were cherry-picked as the men to take over from vice-chairman Dr Ed Snape and Professor Sir Duncan Nichol. They were appointed as of June 16.

Today, the company said: "Both directors bring valuable experience which will be of great assistance to Deltex as it seeks to capitalise on its leading position in ODM in international markets such as the USA. 

"Tim has almost 30 years' experience in the healthcare industry, both in the UK and internationally, specifically in marketing medical products in a number of Deltex's key existing markets. 

"Mark, a partner with Allen & Overy LLP has significant experience advising international companies on their strategic transactions, including advising at board level."

Quick facts: Deltex Medical Group plc

Follow
AIM:DEMG

Price: 1.425 GBX

Market Cap: £8.34 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Base Resources highlights enhanced DFS for Toliara project in Madagascar

Base Resources Ltd's Kevin Balloch talks Proactive through an enhanced definitive feasibility study on its Toliara project in Madagascar. It's revealed a post-tax/pre-debt net present value of US$1bn and a 3.5 average revenue to cost of sales ratio over an initial 38-year mine life. Life-of-mine...

1 hour, 19 minutes ago

2 min read